NanoSeptic Surface Effective Against a Variety of Pathogens
|
By HospiMedica International staff writers Posted on 02 Apr 2014 |
|
Image: A door handle coated with a NanoSeptic Surface (Photo courtesy of NanoTouch Materials).
An innovative disruptive technology provides a new tool in the fight against infection and illness of even the most dangerous pathogens.
The NanoSeptic surface, developed in the Center for Advanced Engineering and Research (CAER; Forest, VA, USA) and manufactured by NanoTouch Materials (Forest, VA, USA), is composed of antimicrobial components that are molecularly bonded on a nanoscale, providing a nonleaching, self-cleaning surface that constantly traps and kills bacteria, viruses, and fungi through a catalytic oxidation process using available light. The surfaces also eventually degrade the endotoxins the are the result of bacterial death.
The surfaces work constantly kill pathogens utilizing nanotechnology rather than chemicals, diluted poisons, or heavy metals, and for a period that lasts 6-12 months, as long as he surface is not worn. Possible applications and targets include facility touch points such as door push-pads and handle wraps, as well as portable mats for counters, tray tables, and bathroom vanities. The surfaces were tested at King Abdul-Aziz University Hospital (KSU; Riyadh, Saudi Arabia) against several types of Gram positive, Gram negative, and Methicillin-resistant Staphylococcus aureus (MRSA) bacteria.
“After receiving the initial test results, we started calling the NanoSeptic products 'Magical Paper' because of their ability to kill bacteria,” said Amr Saeb, PhD, head of biotechnology at KSU. “This product was able to Kill 100% of E. coli and P. aeruginosa and 88% of MRSA germs after only one hour. As a microbial geneticist, I am really excited by the latest approaches to kill pathogens in a safe and environmentally conscious way without generating resistant microbes which are difficult to treat.”
“At NanoTouch, we're so excited that research centers across the globe are validating our ongoing mission—to change the world.” said Dennis Hackemeyer, cofounder of NanoTouch Materials. “Another exciting aspect of NanoSeptic products is the visual communication which has the potential to change behavior. Visitors gravitate toward touching the NanoSeptic surface which keeps other surfaces cleaner.”
Related Links:
Center for Advanced Engineering and Research
NanoTouch Materials
The NanoSeptic surface, developed in the Center for Advanced Engineering and Research (CAER; Forest, VA, USA) and manufactured by NanoTouch Materials (Forest, VA, USA), is composed of antimicrobial components that are molecularly bonded on a nanoscale, providing a nonleaching, self-cleaning surface that constantly traps and kills bacteria, viruses, and fungi through a catalytic oxidation process using available light. The surfaces also eventually degrade the endotoxins the are the result of bacterial death.
The surfaces work constantly kill pathogens utilizing nanotechnology rather than chemicals, diluted poisons, or heavy metals, and for a period that lasts 6-12 months, as long as he surface is not worn. Possible applications and targets include facility touch points such as door push-pads and handle wraps, as well as portable mats for counters, tray tables, and bathroom vanities. The surfaces were tested at King Abdul-Aziz University Hospital (KSU; Riyadh, Saudi Arabia) against several types of Gram positive, Gram negative, and Methicillin-resistant Staphylococcus aureus (MRSA) bacteria.
“After receiving the initial test results, we started calling the NanoSeptic products 'Magical Paper' because of their ability to kill bacteria,” said Amr Saeb, PhD, head of biotechnology at KSU. “This product was able to Kill 100% of E. coli and P. aeruginosa and 88% of MRSA germs after only one hour. As a microbial geneticist, I am really excited by the latest approaches to kill pathogens in a safe and environmentally conscious way without generating resistant microbes which are difficult to treat.”
“At NanoTouch, we're so excited that research centers across the globe are validating our ongoing mission—to change the world.” said Dennis Hackemeyer, cofounder of NanoTouch Materials. “Another exciting aspect of NanoSeptic products is the visual communication which has the potential to change behavior. Visitors gravitate toward touching the NanoSeptic surface which keeps other surfaces cleaner.”
Related Links:
Center for Advanced Engineering and Research
NanoTouch Materials
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Digital Color Doppler Ultrasound System
MS22Plus
Latest Critical Care News
- Specialized Dressing with Sensor Monitors pH Levels in Chronic Wounds
- AI Model Could Help Diagnose Spinal Cord Disease Up To 30 Months Earlier
- 3D-Printed Swallowable Robot Could Perform Gastrointestinal Procedures
- Next-Gen Hydrogel Could Transform Soft Tissue and Organ Repair
- Engineered Cancer Eating Bacteria Consume Tumors from Inside Out
- ‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes
- Smartphone-Linked Catheter Sensor Spots UTIs Sooner Than Lab Cultures
- AI Tool Identifies Trauma Patients Requiring Blood Transfusions Before Reaching Hospital
- New Clinical Guidelines to Reduce Central Line-Associated Bloodstream Infection
- New Inhalable Treatment for TB Lowers Side Effects
- AI Algorithm Improves Antibiotic Decision-Making in Urinary Tract Infection
- 3D-Printed System Enhances Vaccine Delivery Via Microneedle Array Patch
- Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias
- Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems
- AI Stethoscope Spots Heart Valve Disease Earlier Than GPs
- Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
Channels
Artificial Intelligence
view channel
Surgical Techniques
view channel
Brain Implant Records Neural Signals and Delivers Precise Medication
Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more
AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries
Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read moreNeural Device Regrows Surrounding Skull After Brain Implantation
Placing electronic implants on the brain typically requires removing a portion of the skull, creating challenges for long-term access and safe closure. Current methods often involve temporarily replacing the skull or securing metal plates, which can lead to complications such as skin erosion and additional surgeries.... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more